Levosimendan in lung transplant recipients on VA‑ECMO
Chronic heart failure is one of the most dreadful complications in the early postoperative period following lung transplantation. At the same time, the effect of using levosimendan in the early post-lung transplant period is currently insignificant and remains debatable. This paper presents a clinic...
Saved in:
| Main Authors: | S. V. Zhuravel, V. E. Aleksandrova, I. I. Utkina, N. K. Kuznetsova, E. A. Tarabrin |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov
2020-04-01
|
| Series: | Вестник трансплантологии и искусственных органов |
| Subjects: | |
| Online Access: | https://journal.transpl.ru/vtio/article/view/1152 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Use of Levosimendan for the Treatment of Heart Failure and its Potential Organoprotective Effects
by: N. B. Lebedeva, et al.
Published: (2022-05-01) -
CARDIAC PROTECTIVE INOTROPIC THERAPY – OPPORTUNITIES AND PROSPECTIVE OF USING LEVOSIMENDAN IN CARDIAC SURGERY
by: V. V. Pasyuga, et al.
Published: (2018-01-01) -
IMPACT OF LEVOSIMENDAN ON RENAL FUNCTION IN COMPLEX TREATMENT OF ACUTE DECOMPENSATED HEART FAILURE
by: M. V. Lediakhova, et al.
Published: (2018-05-01) -
Pharmacokinetics of levosimendan in critically Ill children on extracorporeal membrane oxygenation: a prospective observational study
by: Stéphane Bertin, et al.
Published: (2025-07-01) -
SUCCESSFUL MEDICATION THERAPY OF ACUTE RIGHT VENTRICLE INSUFFICIENCY IN RECIPIENT WITH SIGNIFICANT PULMONARY HYPERTENSION AFTER HEART TRANSPLANTATION
by: A. M. Chernyavskiy, et al.
Published: (2014-12-01)